Loading the player ...
Rare Diseases Research: Clinical Trial for Niemann-Pick Type CDetermined to find a treatment for children with the degenerative brain disease Niemann-Pick Type C, Steven Walkley, D.V.M., Ph.D., turned a serendipitous laboratory discovery into a successful national research collaboration with other academic institutions and the National Center for Advancing Translational Sciences, part of the NIH. These efforts led to an NIH Phase 1 clinical trial testing cyclodextrin as a therapy for children with this disease. Dr. Walkley is a professor in the Dominick P. Purpura Department of Neuroscience and director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center at Einstein. (April 29, 2014)
for Children and Adults with Developmental Disabilities (11:36)
and Developmental Disabilities (7 of 7) (3:36)
and Developmental Disabilities (6 of 7) (2:08)